Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 11, 2009Multaq(R) (dronedarone) significantly reduced the risk of cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation
-
Feb 5, 2009Team Type 1 Expands Its Roster, Fielding Five Teams to Spread Personal Messages of Successful Diabetes Management to People Living with Type 1 and Type 2 Diabetes
-
Nov 11, 2008New post-hoc analysis from Athena Study showed that Multaq® on top of standard therapy significantly decreased the total number of hospital days by 28% in patients with atrial fibrillation or flutter
-
Oct 23, 2008Sanofi-aventis will comply with the European Authorities request to temporarily suspend the marketing authorisation of Acomplia® in obese and overweight patients and will make every effort to actively support patients and Health Care Professionals.
-
Oct 16, 2008Champions Hope to Inspire People Living with Uncontrolled Blood Sugar Levels to Join the Circle and Pledge to Get Serious About Managing Their Diabetes
-
Sep 23, 2008Randomized, double-blind, placebo-controlled study conducted in the U.S. demonstrated both the efficacy and safety of Nasacort AQ® in children with nasal symptoms associated with perennial allergic rhinitis
-
Sep 16, 2008Actress Phylicia Rashad Travels to P.A.D. “Hot Spots” During P.A.D. Awareness Month to Urge Diagnosed Residents to Seek Treatment
-
Sep 15, 2008McGill and Nationally Known Allergist Encourage Nasal Allergy Sufferers to Challenge Their Course and Offer Helpful Tips for the Fall
-
Sep 3, 2008This analysis showed that Multaq® (dronedarone) decreased the risk of stroke by 34% in patient with atrial fibrillation or atrial flutter already adequately treated by antithrombotic therapy
-
Jul 22, 2008Two Regimens Including Lantus® and Apidra® Resulted in Significant Reductions in A1C in Patients with Type 2 Diabetes, Whatever the Algorithm Used
-
Jun 19, 2008Schmidt teams up with Minor League BaseballTM to raise awareness of Benign Prostatic Hyperplasia (BPH), a condition affecting more than 8 million men in the U.S.
-
Jun 10, 2008Ambien CR® 12.5 mg significantly improved sleep onset, sleep maintenance and total sleep time compared to placebo
-
Jun 7, 2008Results Presented at the ADA’s Annual Scientific Sessions
-
Jun 7, 2008New data presented at the ADA’s Annual Scientific Sessions demonstrated the value of beginning insulin promptly when glycemic targets are not achieved with diet, exercise and oral medications alone
-
May 28, 2008FDA Approval Based on Updated Results Showing a 20% Reduction in the Risk of Death at Six Years and a 22% Improvement of Disease Free Survival at Five Years, For Stage III Colon Cancer, Post Surgery
-
May 27, 2008First Phase III study performed solely in high risk, node-negative high risk population to show significant improvement in Disease Free Survival (DFS)
-
May 5, 2008100% of Insulin Doses Administered Were Delivered Within Pre-Determined Guidelines and Standard Dosing Limitations
-
May 1, 2008Web Site Provides Expert Advice and Answers to Acne-Related Questions